Liberty One战术收益主动型ETF LOTI 深 沪
等待开盘 02-20 09:30:00 美东时间
26.1954
+0.040
+0.15%
华盛通- 最 高26.20
- 今 开26.17
- 成交量 4436股
- 最 低 26.17
- 昨 收 26.1554
- 总市值 3693.55万
- 52周最高 26.31
- 市盈率 静 --
- 换手率 0.31%
- 52周最低 24.995
- 委 比 0.00%
- 总股本 141.00万
- 历史最高 26.31
- 量 比 0.31
- 振 幅 0.11%
- 历史最低 24.995
- 每 手 1
- 风险率 0.27%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多BRIEF-Energy Fuels' US-Produced "Heavy" Rare Earth Oxide Successfully Qualified For Use In Permanent Magnets
Dec 19 (Reuters) - Energy Fuels Inc UUUU.A: ENERGY FUELS' US-PRODUCED "HEAVY" RARE EARTH OXIDE SUCCESSFULLY QUALIFIED FOR USE IN PERMANENT MAGNETS ENERGY FUELS INC: PLANS TO BEGIN PILOTING TERBIUM OXI...
2025-12-19 19:30
BRIEF-Elanco's Credelio Quattro™-Ca1 Receives First FDA Conditional Approval
Dec 18 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO'S CREDELIO QUATTRO™-CA1 (LOTILANER, MOXIDECTIN, PRAZIQUANTEL, AND PYRANTEL CHEWABLE TABLETS) RECEIVES FIRST FDA CONDITIONAL APPROVAL FOR TREA...
2025-12-18 22:11
BRIEF-Adc Therapeutics Announces Updated Data From Lotis-7 Phase 1B Clinical Trial Of Zynlonta
Dec 3 (Reuters) - ADC Therapeutics SA ADCT.N: ADC THERAPEUTICS ANNOUNCES UPDATED DATA FROM LOTIS-7 PHASE 1B CLINICAL TRIAL OF ZYNLONTA® IN COMBINATION WITH BISPECIFIC ANTIBODY SUPPORTING POTENTIAL BES...
2025-12-03 20:32
BRIEF-Marqeta Announces Appointment Of Mike Milotich As CEO
Sept 8 (Reuters) - Marqeta Inc MQ.O: MARQETA ANNOUNCES APPOINTMENT OF MIKE MILOTICH AS CEO MARQETA INC - MIKE MILOTICH TO CONTINUE AS CFO UNTIL SUCCESSOR FOUND Source text: ID:nBwbZ0LD7a Further compa...
2025-09-08 20:11
BRIEF-Elanco Sells Royalty And Milestone Rights For Lotilaner In Human Health To Blackstone Accelerates Debt Paydown
May 5 (Reuters) - Elanco Animal Health Inc ELAN.N: ELANCO SELLS ROYALTY AND MILESTONE RIGHTS FOR LOTILANER IN HUMAN HEALTH TO BLACKSTONE; ACCELERATES DEBT PAYDOWN ELANCO ANIMAL HEALTH INC - SELLS ROYA...
2025-05-05 18:28
